These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 18039100)

  • 1. VEGF-A and the induction of pathological angiogenesis.
    Nagy JA; Dvorak AM; Dvorak HF
    Annu Rev Pathol; 2007; 2():251-75. PubMed ID: 18039100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
    Takahashi H; Shibuya M
    Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS; Stoeltzing O; Ellis LM
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular endothelial growth factor family and its receptors.
    Parikh AA; Ellis LM
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):951-71, vii. PubMed ID: 15474329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases.
    Grimm D; Bauer J; Schoenberger J
    Curr Vasc Pharmacol; 2009 Jul; 7(3):347-57. PubMed ID: 19601859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and its receptors.
    Klagsbrun M; D'Amore PA
    Cytokine Growth Factor Rev; 1996 Oct; 7(3):259-70. PubMed ID: 8971481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of VEGF in the regulation of physiological and pathological angiogenesis.
    Ferrara N
    EXS; 2005; (94):209-31. PubMed ID: 15617481
    [No Abstract]   [Full Text] [Related]  

  • 13. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of vascular endothelial growth factor.
    Nieves BJ; D'Amore PA; Bryan BA
    Biofactors; 2009; 35(4):332-7. PubMed ID: 19415738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of platelet in angiogenesis].
    JIN W; XU ZP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):427-32. PubMed ID: 19693984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis.
    Harry LE; Paleolog EM
    Birth Defects Res C Embryo Today; 2003 Nov; 69(4):363-74. PubMed ID: 14745976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3: a critical transcription activator in angiogenesis.
    Chen Z; Han ZC
    Med Res Rev; 2008 Mar; 28(2):185-200. PubMed ID: 17457812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
    Kiselyov A; Balakin KV; Tkachenko SE
    Expert Opin Investig Drugs; 2007 Jan; 16(1):83-107. PubMed ID: 17155856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
    Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
    EXS; 1997; 79():233-69. PubMed ID: 9002222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.